MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on February 8, 2006; DOI: 10.1124/mol.105.019802


0026-895X/06/6905-1588-1598$20.00
Mol Pharmacol 69:1588-1598, 2006

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.105.019802v1
69/5/1588    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Koshimizu, T.-a.
Right arrow Articles by Tsujimoto, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Koshimizu, T.-a.
Right arrow Articles by Tsujimoto, G.

Carboxyl-Terminal Splicing Enhances Physical Interactions between the Cytoplasmic Tails of Purinergic P2X Receptors

Taka-aki Koshimizu, Karla Kretschmannova, Mu-Lan He, Susumu Ueno, Akito Tanoue, Nobuyuki Yanagihara, Stanko S. Stojilkovic, and Gozoh Tsujimoto

Department of Genomic Drug Discovery Science, Graduate School of Pharmaceutical Sciences Kyoto University Faculty of Pharmaceutical Sciences, Kyoto University, Kyoto, Japan (T.K., G.T.); Endocrinology and Reproduction Research Branch, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland (K.K., M-L.H., S.S.S.); Department of Pharmacology, University of Occupational and Environmental Health, Japan School of Medicine, Fukuoka, Japan (S.U., N.Y.); and Department of Molecular and Cell Pharmacology, National Research Institute for Child Health and Development, Tokyo, Japan (T.K., A.T.)

Received October 12, 2005; accepted February 8, 2006


    Abstract
 Top
 Abstract
 Materials and Methods
 Results
 Discussion
 References
 
Purinergic P2X receptors are ion-conducting channels composed of three subunits, each having two transmembrane domains and intracellular amino (N) and carboxyl (C) termini. Although alternative splicing extensively modifies the C-terminal sequences of P2X subunits, the direct influence of such post-transcriptional modifications on receptor architecture and function remains poorly understood. In this study, we focused on mouse pituitary P2X2 receptors. In this tissue, progressive splicing of the P2X2a C terminus generated two functional subunit variants, P2X2b and P2X2e, which exhibited accelerated desensitization rates and attenuated calcium signals when the receptors were in homomeric states. To measure the intersubunit interaction in living cells, the efficient transfer of bioluminescent resonance energy between luciferase and fluorescent proteins attached to the N- or C-subunit termini of these subunits was used. The constitutive interactions between the full-length C termini of P2X2a receptor were detected by a significant increase in fluorescence/luminescence intensity ratio compared with negative controls. Moreover, interactions between C termini and between C- and N termini of adjacent subunits were significantly enhanced in homomeric and heteromeric receptors containing P2X2b or P2X2e subunits. Finally, deletion of two amino acids at the splicing junction, but not at the C-terminal end of the P2X2b receptor, resulted in the enhancement of channel desensitization and luminescence resonance energy transfer. These results indicate that C-terminal structure plays a critical role in the cytoplasmic intersubunit interactions and suggest that the extent of subunit interactions before ATP application could contribute to the subsequent channel activity and conformation changes associated with agonist-dependent desensitization.


P2X receptors, a family of plasma membrane ligand-gated channels, generate a nonselective cationic current in response to activation by extracellular ATP (Ralevic and Burnstock, 1998Go; Vial et al., 2004Go). P2X receptors exist as homomeric or heteromeric proteins of three subunits. This architecture has been confirmed by biochemical and mutagenesis studies, as well as by atomic microscopy (Nicke et al., 1998Go; Jiang et al., 2003Go; Barrera et al., 2005Go). Each of the P2X subunits consists of two transmembrane {alpha}-helixes connected by a large extracellular loop and intracellular amino (N) and carboxyl (C) termini (Newbolt et al., 1998Go; Ralevic and Burnstock, 1998Go; Torres et al., 1998Go; North, 2002Go). Both the N and C termini serve as molecular targets for a series of post-transcriptional modifications, including RNA splicing, phosphorylation, and protein-protein interactions with other regulatory molecules (Denlinger et al., 2001Go; Kim et al., 2001Go; Royle et al., 2002Go; Boue-Grabot et al., 2003Go, 2004Go; Gendreau et al., 2003Go; Khakh et al., 2005Go). However, the structural changes introduced into cytoplasmic tails by post-translational modification, particularly in terms of the relationship between the N and C termini, were not studied in detail.

In the anterior pituitary, inner ear, and other brain regions, the primary P2X2 gene transcript undergoes extensive alternative splicing, resulting in modified mRNA sequences. The spliced subunit, termed P2X2b, lacks a series of C-terminal 69 amino acids and creates a functional homomeric channel, which desensitizes more rapidly than the full-size receptor, termed P2X2a (Brandle et al., 1997Go; Simon et al., 1997Go; Koshimizu et al., 1998bGo; Parker et al., 1998Go; Troyanovskaya and Wackym, 1998Go). Electrostatic charges of six amino acid side chains located near the proximal splicing site play a critical role in controlling the rate of receptor desensitization (Koshimizu et al., 1999Go). The C-terminal amino acids of rat P2X2a are also responsible for time- and activation-dependent changes in the permeability induced by channel pore dilation (Khakh et al., 1999Go; Virginio et al., 1999Go; Eickhorst et al., 2002Go; Fisher et al., 2004Go). On the other hand, phosphorylation of an N-terminal site by protein kinase C significantly accelerates channel desensitization (Boue-Grabot et al., 2000Go). Although these earlier experiments demonstrate consistent allosteric effects associated with the modification of P2X2 subunit tails leading to changes in channel activity, the possibility of mutual interaction between the N and C termini within oligomeric channel architecture was not investigated.

The principal aim of our present study was to directly examine the subunit interactions between N and C termini of mouse P2X receptor splicing isoforms in homomeric and heteromeric configurations and to understand the functional significance of these interactions. To this end, the naturally occurring splicing variants of P2X channels in mouse pituitary were studied by the measurement of bioluminescent resonance energy transfer (BRET) from luciferase (Luc)-tagged C termini to green fluorescent protein (GFP)-tagged N and C termini. The use of P2X2e, which has a shorter C terminus than P2X2b and desensitizes more rapidly, greatly facilitated our understanding of C-terminal interactions. Our results suggest that heteromeric P2X2 channels are formed by any combination of the three P2X2 splicing subunits found in the pituitary and that conformational constraints generated by splice reactions can enhance energy transfer efficiency and bring the spliced tails near other subunit tails.


    Materials and Methods
 Top
 Abstract
 Materials and Methods
 Results
 Discussion
 References
 
cDNA Cloning and Expression Analysis of P2X2 Isoforms. The coding sequence of the mouse P2X2 receptor was obtained from pituitary total RNA by RT-PCR. The 5'- and 3'-untranslated regions were obtained by RACE PCR (rapid amplification of cDNA ends) (Clontech, Mountain View, CA). The primer sequences were designed from the rat P2X2a receptor coding sequence (Brake et al., 1994Go) and were as follows: 495U (5'-GGACTCCAAGACCTGCGAGGTGT-3') for sense, L1071 (5'-ACAAAATCCAGTCACACAGGAAG-3') for antisense, U803 (5'-GGAACTGTGACCTGGACTTG-3') for 3'-RACE, and two antisense primers, L598 (5'-TTGGGGTAGTGGATGCTGTTCTT-3') and L43 (5'-TCACCTTGGGCGTCTCGTAGTC-3') for 5'-RACE. Amplified fragments were subcloned, and at least two independent clones were sequenced using the dideoxy chain termination method and a Megabase 1000 fluorescent sequencer (GE Healthcare, Little Chalfont, Buckinghamshire, UK). The entire protein-coding regions for the P2X2 subunits were constructed by joining the 5'- and 3'-RACE products.

The tissue distribution of P2X2 splicing isoforms was determined by RT-PCR using a pair of PCR primers that encompass spliced regions: U803 (sense, see earlier for sequence) and L1468 (antisense, 5'-CCAGGTCCAGGTCTGTAGCTTA-3'). Amplified PCR products were separated by agarose electrophoresis and then examined by Southern blot analysis using an oligonucleotide probe prepared with primer L1008 (5'-TGATGATGGTGGGAATGAGACTGAAT-3'), which is common to all P2X2 isoforms. After hybridization and washing, blots were exposed to image intensifying screens for 12 h and visualized with the aid of a Storm PhosphorImager (Amersham Biosciences).

Expression of P2X2 Receptors in Mammalian Cells and Current and Intracellular Calcium Measurement. GT1-7 immortalized neurons (GT1 cells) were cultured in Dulbecco's modified Eagle's medium and Ham's F12 medium (1:1). Human embryonic kidney (HEK) 293 cells were cultured in Dulbecco's modified Eagle's medium (Invitrogen, Groningen, The Netherlands). Both media were supplemented with 10% fetal calf serum, penicillin (50 U/ml) and streptomycin (50 µg/ml). cDNA inserts that had been cloned into the pcDNA3.1 vector (Invitrogen) using XhoI and BamHI restriction sites were used for transient transfections involving a cationic liposome approach as described previously (Koshimizu et al., 1998aGo). Single-cell [Ca2+]i recordings were performed 24 to 48 h after transfection in GT1 cells, as described previously (Koshimizu et al., 1998aGo). Electrophysiological recordings were done in both GT1 and HEK cells 24 to 48 h after transfection. Cells were continuously perfused with an extracellular solution containing 150 mM NaCl, 3 mM KCl, 2 mM CaCl2, 1 mM MgCl2, 10 mM HEPES, and 10 mM glucose. The pH was adjusted to 7.3 with NaOH. Patch pipettes were pulled from borosilicate glass (World Precision Instruments, Sarasota, FL) and heat polished to a tip resistance of 6 to 7 M{Omega}. Pipette solution contained 90 mM K-aspartate, 50 mM KCl, 3 mM MgCl2,10 mM HEPES, and 10 mM EGTA, adjusted to pH of 7.2 with KOH. Voltage-clamp recordings were performed using Axopatch 200B amplifier (Molecular Devices, Sunnyvale, CA). Cells were held at -30 mV throughout recording.

Immunological Detection of P2X2 Receptors. PCR was used to insert the FLAG epitope, DYKDDDDK, between the initial methionine residue and the second amino acid of the P2X2 subunit. The 5'-primer was composed of the following sequences: a XhoI site (six bases), an optimized translational sequence (Kozak, 1989Go), a methionine residue (three bases), 24 bases encoding the 8-residue FLAG-peptide sequence, and 21 bases encoding seven residues alongside the initial methionine. The 3'-primer for FLAG-tagging was designed between nucleotides 541 and 562 of P2X2a. Correctly tagged PCR fragments were transferred to expression constructs using XhoI and NarI restriction sites for N-terminal substitutions. Expressed P2X2 constructs were detected with an antibody raised against the P2X2a C terminus (1:400; Chemicon International Inc., Temecula, CA) or with an anti-FLAG M2 antibody (1:2000; Kodak, Rochester, NY) as described previously (Koshimizu et al., 2002Go). The secondary antibody used was a peroxidase-conjugated anti-mouse or anti-rat secondary antibody (1:5000; Amersham Biosciences) and signals were visualized by enhanced chemiluminescence (Amersham Biosciences). For immunoprecipitation, 1 µg of antibody was incubated with 1 mg of cellular lysate (50 mM Tris-HCl, pH 7.4, 100 mM NaCl, 0.5% Nonidet P-40, and proteinase inhibitor cocktail; Roche, Basel, Switzerland) at 4°C for 1 h and precipitated with protein G Sepharose (Amersham Biosciences). Protein concentrations were determined using the Pierce BCA protein assay kit (Pierce, Rockford IL).

Expression in Xenopus laevis Oocytes and Electrophysiological Recordings. Oocytes (at developmental stages V and VI) were isolated from adult X. laevis as described previously (Beckstead et al., 2000Go) and placed in modified Barth's saline containing 88 mM NaCl, 1 mM KCl, 10 mM HEPES, 0.82 mM MgSO4, 2.4 mM NaHCO3, 0.91 mM CaCl2, and 0.33 mM Ca(NO3)2 at pH 7.5. The oocyte nuclei were injected directly with 0.5 ng of each expression construct (P2X2a, P2X2b,orP2X2e) in 30 nl of injection buffer (88 mM NaCl, 1 mM KCl, and 15 mM HEPES, pH 7.0). Injected oocytes were maintained for 2 days at 18°C in sterile incubation medium containing modified Barth's saline plus 10 µg/ml streptomycin, 10 units/ml penicillin, 50 µg/ml gentamicin, and 2 mM sodium pyruvate. For electrophysiological recording, oocytes were placed in a rectangular chamber (100-µl volume) and perfused with Ba2+-Ringer's solution (115 mM NaCl, 2.5 mM KCl, 1.8 mM BaCl2, and 10 mM HEPES, pH 7.4) at a rate of 2 ml/min. The oocytes were then impaled with two glass electrodes (0.5-10 M{Omega}) prefilled with 3 M KCl and were subsequently voltage-clamped at -50 mV using an OC-725C oocyte clamp amplifier (Warner Instruments, Inc., Hamden, CT). Currents were digitally recorded with a PowerLab/200 system along with Chart software (ADInstruments, Grand Junction, CO). ATP was dissolved in distilled water and then diluted in Ba2+-Ringer's solution immediately before use and applied for 30 s. All measurements were performed at ambient temperature.

Construction of Mutant Subunits. Mutant P2X2 subunits were created by PCR. For the N-terminally deleted P2X2 subunits, which lack the first 13 amino acids but retain the second AUG codon, PCR primers U1 (5'-GGCCGTGTGGGGTGTTCATCTCT-3') and L1468 (see cDNA Cloning and Expression Analysis of P2X2 Isoforms for sequence) were used. The primer used to delete two amino acids at the distal end of the P2X2b subunits was 5'-GGTACCGGCCAAACCTTTGGGGTCCGTGGATGTGG-3'. Two further amino acids were removed at the proximal splicing junction using two overlapping primers: 5'-GGTCAAGAGTGTCCTTGTCGAACTTCTTATGG-3' and 5'-AAGTTCGACAAGGACACTCTTGACCAGCATATGGGAC-3'. The PCR products were subcloned and sequenced, and the verified inserts were subsequently directionally cloned into the pcDNA vector using XhoI and BamHI restriction sites.

BRET Assay. The cDNAs encoding each of the P2X receptors were fused in-frame with the coding sequences for either yellow fluorescent protein (YFP) or Renilla reniformis luciferase gene (Luc; Promega) by changing the native stop codon to a KpnI restriction enzyme site, resulting in two amino acid insertions of glycine and asparagine between the receptor and either YFP or Luc. For YFP, a brighter variant, Venus (F64L/M153T/V163A/S175G) (Nagai et al., 2002Go), was used. All fusion constructs were sequenced and subsequently cloned into the pcDNA3.1 vector (Invitrogen). For Luc-connected P2X2 subunit, N-terminal FLAG epitope was inserted as described above. Expression of GFP and YFP fusion receptors were confirmed by monoclonal anti-GFP antibody (1:2000; MBL, Tokyo, Japan).

For BRET assays, transfected cells were grown on a 10-cm culture dish, collected in PBS containing 1 mM EDTA and then suspended in Hanks'/HEPES buffer at a concentration of 1 x 106/ml. Luminescence spectra were measured by a fluorescence spectrophotometer (F-4500; Hitachi, Tokyo, Japan) after the addition of coelenterazine h (Promega) at a final concentration of 5 µM. The BRET signal was then determined by calculating the signal ratio of the light emitted by the receptor-YFP fusion at 535 nm or the receptor-GFP fusion at 515 nm to the light emitted by the receptor-Luc fusion at 480 nm. The background signal was determined before the addition of coelenterazine h and was subtracted from experimental values. The background signal intensity was always less than 1% of the measured values. Steady-state fluorescence anisotropy was measured in a suspension of cells at a concentration of 105/ml expressing fluorescent protein-tagged receptors. This procedure was performed in assay buffer containing 137 mM NaCl, 5 mM KCl, 1.2 mM CaCl2, 1 mM MgCl2, 10 mM HEPES, and 10 mM glucose using a computer-controlled and thermostatically-regulated spectrophotofluorimeter (MPF-2A; Hitachi, Tokyo, Japan).

Calculations. All data are represented as mean ± S.E.M. values. Significant differences, with P < 0.05, were determined by one-way analysis of variance followed by Newman-Keuls multiple comparison test. Concentration-response relationships were fitted to a four-parameter logistic equation using a nonlinear curve-fitting program, from which the EC50 and Hill values were derived (Kaleidagraph; Synergy Software, Reading, PA). The declining phases of the observed calcium responses were fitted to single-exponential functions (Prism; GraphPad Software, San Diego, CA) and results were assessed according to the "extra sum of squares" principle, as described previously (Koshimizu et al., 2002Go).


    Results
 Top
 Abstract
 Materials and Methods
 Results
 Discussion
 References
 
Splicing Variants of P2X2 Subunit in Mouse Pituitary. In the anterior pituitary tissue of mice, we identified three C-terminal splicing variants, termed P2X2a, P2X2b, and P2X2e (Fig. 1A). The P2X2b subunit lost a stretch of 69 amino acids in keeping with the original reading flame and C-terminal end, which is entirely consistent with prior literature (Brandle et al., 1997Go; Simon et al., 1997Go; Koshimizu et al., 1998bGo; Troyanovskaya and Wackym, 1998Go; Housley et al., 1999Go). In P2X2e subtype, 90 amino acids are deleted from the C terminus (from Val383 to Glu472), and the C-terminal end was preserved (Fig. 1A). A splicing pattern similar to the pituitary P2X2e was previously reported as a partial transcript isolated from rat vestibular end-organs, but the functional properties of this subunit were not investigated (Troyanovskaya and Wackym, 1998Go). In contrast to rat P2X2 subunits, the cytoplasmic N terminus of three mouse P2X2 subunits contained additional 13 amino acids. RT-PCR analysis revealed that the P2X2a subunit was the most abundant transcript and was detected in a variety of tissues, whereas the P2X2e subunit was detected only in the pituitary (Fig. 1, B and C). When P2X2 subunits were separately expressed in HEK (Fig. 1D) and GT1 cells (data not shown), the differences in molecular mass between spliced and full-length P2X2 variants were immunologically detected by Western blot analysis. Relatively broad bands seen on the blot indicate the glycosylated mature subunits. In cells expressing P2X2a, no additional lower band corresponding to the spliced P2X2b or P2X2e was detected, suggesting that further splicing reaction on the full-length C terminus did not occur in these cells.


Figure 1
View larger version (46K):
[in this window]
[in a new window]
 
Fig. 1. C-terminal structures and expression patterns of mouse P2X2 isoforms. A, schematic representation and cytoplasmic C-terminal sequences of mouse P2X2 receptors. N and C represent amino and carboxyl termini, respectively. TM1 and TM2, first and second transmembrane domains, respectively. Sequences spliced out are shown as dashed lines. All splicing donor and acceptor sites follow GT/AG rule (underlined). The nucleotide base pairs (bp), starting at the initial AUG codon, are indicated at right. B, expression of the P2X2 receptor in mouse pituitary was examined by RT-PCR using a primer set that detects different C-terminal splicing patterns. Southern blotting and hybridization with a probe common to all P2X2 isoforms detected three splicing variants. The expected lengths of the PCR products for P2X2a, P2X2b, and P2X2e were amplified from cDNAs 686-, as 479-, and 416-bp bands, respectively. RT+ and RT-indicate cDNAs prepared with and without the reverse transcriptase transcription step. C, tissue-specific expression profiles of the P2X2 isoforms were examined in: B, whole brain; Sp, spinal cord; H, heart; L, lung; K, kidney; Li, liver; Pa, pancreas; Ad, adrenal grand; M, neonatal cardiomyocyte; and Fi, fibroblast. V, as a positive control mixture of cDNAs for P2X2a, P2X2b, and P2X2e was used; and water (W) as a negative control. D, Western blot analysis of P2X2 isoforms. FLAG-tagged P2X2 isoforms expressed in HEK cells were immunologically detected on the membrane. Kd, molecular mass markers.

 
Signaling Patterns by Native and Mutant Receptors. We expressed these subunits in mammalian GT1 and HEK cells, as well as in X. laevis oocytes, to evaluate the impact of different C-terminal splicing patterns on channel function. When expressed as homomeric channels in GT1 and HEK cells, the full-length and two spliced P2X2 receptors were functional, as indicated by generation of high amplitude inward currents in response to 100 µM ATP application (Fig. 2). However, channels generated different pattern of currents during the prolonged application of ATP. P2X2a receptor desensitized with the time constants ({tau}des) of approximately 10 s and 12 s in GT1 and HEK cells, respectively (Fig. 2A). In both cell types, P2X2b desensitized more rapidly, with time constants of approximately 5 s (Fig. 2B). The additional reduction in C-terminal sequence in P2X2e spliced form resulted in a channel that desensitized with {tau}des between 0.5 and 0.7 s, rates highly comparable with those of the rapidly desensitizing P2X1 and P2X3 receptors (Fig. 2C).


Figure 2
View larger version (15K):
[in this window]
[in a new window]
 
Fig. 2. Patterns of 100 µM ATP-induced current profiles of P2X2 receptors expressed in mammalian GT1 (left) and HEK cells (right). A-C, representative traces of P2X2a (A), P2X2b (B), and P2X2e (C) currents during the prolonged application of ATP. Numbers below traces indicate the mean ± S.E.M. values of rates of receptor desensitization. Single exponential functions were applied to describe the desensitization rates ({tau}des). Numbers in parentheses indicate number of cells. *, P < 0.05 versus P2X2a; **, P < 0.01 versus P2X2b receptor.

 
Experiments with single-cell calcium measurements were done only in GT1 cells, because HEK cells express calcium-mobilizing P2Y receptors (He et al., 2003Go). All three channels responded to application of ATP with rapid and concentration-dependent increases in [Ca2+]i, exhibiting comparable EC50 values (10, 4, and 12 µM for P2X2a, P2X2b, and P2X2e, respectively; n = 8-14). However, in all ATP doses applied, the peak amplitude of [Ca2+]i signals in P2X2e-expressing cells were significantly lower compared with responses observed in P2X2a and P2X2b-expressing cells (Fig. 3). The desensitizing rates of ATP-induced [Ca2+]i signals were also dependent on ATP concentration; the calculated EC50 values for [Ca2+]i decay rate were 25, 50, and 16 µM for P2X2a, P2X2b, and P2X2e, respectively (n = 7-12). As in current measurements (Fig. 2), the three channels differed in the decay rates of [Ca2+]i after peak values when stimulated with 100 µM ATP (Fig. 3). We also found that there were significant differences in plateau [Ca2+]i values among the three isoforms. Five minutes after the peak increase, the reductions in [Ca2+]i were 62.3 ± 2, 83.7 ± 1.4, and 94.5 ± 0.6% for P2X2a, P2X2b, and P2X2e, respectively.


Figure 3
View larger version (23K):
[in this window]
[in a new window]
 
Fig. 3. Patterns of ATP-induced [Ca2+]i profiles in GT1 cells expressing mouse P2X2 isoform receptors. A-C, dose-dependent activation and desensitization of homomeric P2X2a (A), P2X2b (B), and P2X2e receptors (C). In this and the following figures, experimental records are shown by circles (mean values from at least 15 traces in representative experiments) and fitted curves are shown by full lines. Single exponential functions were applied to describe the desensitization rates. Agonists were added to a final concentration, which is indicated above the traces and were continuously present during the recording (horizontal bars). Dose-dependent peak [Ca2+]i amplitudes (right, {circ}) and desensitization rates (right, bullet) were plotted against ATP concentrations. Dotted vertical lines indicate the calculated EC50 values.

 

Consistent with single-cell current and calcium measurements in mammalian cells, the electrophysiological examination of the three splicing variants expressed in X. laevis oocytes revealed differences in the rates of receptor desensitization in response to supramaximal (100 µM) concentrations of agonist (Fig. 4, B and C). However, the rates of current decay in the presence of agonists were slower for all three receptors compared with the rates observed in mammalian cells, indicating the cell-type specificity in the expression of P2X2 receptors. Differences in current kinetics were observed for P2X4 receptor, when the receptor was expressed in mammalian cells and X. laevis oocytes (North, 2002Go).


Figure 4
View larger version (17K):
[in this window]
[in a new window]
 
Fig. 4. Functional expression of mouse P2X2 isoforms in X. laevis oocytes. A, schematic representations of C-terminal splicing and N-terminal deletion constructs. Three P2X2 variants were deleted for 13 amino acids at their N termini (labeled as {Delta}1-13). B, current kinetics of native and mutant P2X2 receptors. ATP (100 µM) was applied for 30 s as indicated by the horizontal bars above traces. C, the decay phase of the current response was plotted against time after peak activation (mean ± S.E.M. values, n = 7). Significant differences (P < 0.05) were observed between wild type (filled symbols) and N-terminally deleted (open symbols) subunit constructs of P2X2a (circles), P2X2b (squares) and P2X2e (triangles), respectively.

 

To examine the relevance of 13 N-terminal residues of mouse P2X2, which are not present in rat receptors, on channel activity, we generated three mutants by deleting these residues (termed P2X2a{Delta}1-13, P2X2b{Delta}1-13, and P2X2e{Delta}1-13; Fig. 4A) and expressed them in X. laevis oocytes and GT1 cells. As shown in Fig. 4, B and C, N-terminal deletion introduced together with progressive splicing at the C termini had additive effects on accelerating rates of receptor desensitization. The combined effects of C- and N-terminal deletion on single cell [Ca2+]i profiles was also evident in [Ca2+]i measurements in GT1 cells expressing P2X2a and P2X2b wild-type and mutant receptors (Fig. 5). In the case of P2X2e and P2X2e{Delta}1-13, [Ca2+]i kinetics were comparable, probably reflecting the resolution limit in these measurements. We also found that deletion at the N terminus did not affect steady [Ca2+]i levels 5 min after the peak increase (Fig. 5). Finally, the EC50 values of the N-terminal deletion mutants were not significantly altered compared with values for P2X2a (12, 7, and 8 µM, for P2X2a{Delta}1-13, P2X2b{Delta}1-13, and P2X2e{Delta}1-13, respectively). Therefore, the deletion of N-terminal ends of mouse P2X2 subunits accelerates receptor desensitization, and this N-terminal deletion and the C-terminal splicing have an additive effect on the rates of receptor desensitization.


Figure 5
View larger version (28K):
[in this window]
[in a new window]
 
Fig. 5. Calcium signals in GT1 cells expressing native and mutant mouse P2X receptors. A-C, wild type and N-terminally deleted P2X2a (A), P2X2b (B), and P2X2e (C) were expressed separately in GT1 cells and stimulated with 100 µM ATP. Left, representative traces of mean values from a single experiment performed simultaneously on 15 to 45 cells. Right, mean ± S.E.M. values for calculated desensitization rates (left) and steady state [Ca2+]i levels (right) are indicated, with a sample size of between five and eight independent experiments. Desensitization level (%) scales indicate the percentage of decline in peak [Ca2+]i response at 400 s of recording after subtracting basal [Ca2+]i levels. *, P < 0.05, compared with subunits with intact N termini. WT, P2X2 isoforms with a full N terminus; Mutant, N-terminal deletion mutants.

 
Detection of Intersubunit Interactions between Cytoplasmic Tails by BRET. To visualize protein-protein interactions between the cytoplasmic tails of channel-forming subunits, we measured the bioluminescent resonance energy transfer from Luc tagged at the C terminus subunit to GFP tagged to the N terminus or to YFP tagged to the C terminus. The addition of Luc or fluorescent proteins to any of the P2X2 subunit constructs described here caused no detectable changes in the pattern of receptor expression at the plasma membrane or alteration in the channel function in terms of EC50 value, peak [Ca2+]i response to ATP, or the rate of calcium signal decay. Figure 6A illustrates the dose dependence of ATP-induced [Ca2+]i responses for P2X2a-YFP and P2X2a-Luc constructs, with the EC50 values highly comparable with those of the nontagged receptors (Fig. 3). Figure 6B, top, shows the plasma membrane localization of the receptors with YFP tagged at C termini, whereas Fig. 6B, bottom, illustrates the profiles of Ca2+ signals in GT1 cells expressing these constructs. These results clearly indicate that the subunit-specific Ca2+ signals are preserved after C-terminal modifications.


Figure 6
View larger version (44K):
[in this window]
[in a new window]
 
Fig. 6. Functional expression of N- or C-terminally tagged P2X2 subunits. A, dose-response curves were constructed using single GT1 cell [Ca2+]i measurements and ATP as an agonist. Each point represents the mean ± S.E.M. value from 15 to 33 traces collected from five experiments. B, top, intracellular localization of YFP-tagged subunits in HEK cells 48 h after transient transfection detected by confocal microscopy. B, bottom, typical profiles of ATP (50 µM)-induced changes in [Ca2+]i in GT1 cells expressing YFP-tagged P2X2 subunits. C, immunological detection of tagged P2X2 subunit. GFP- or Luc-tagged subunits were detected as expected molecular mass. No additional splicing product was observed in cells expressing P2X2a and P2X2b. D, heteromer formation between differentially tagged P2X2 subunits. YFP-tagged P2X2 subunits and Flag-P2X2a-Luc constructs were examined for their coimmunoprecipitation. Cellular lysate was incubated antigen-antibody complex with anti-Flag antibody and was precipitated with protein G-Sepharose. Signals from YFP antibody were detected on a Western blot membrane only from cells expressing both YFP- and Luc-tagged subunits. Kd, molecular mass markers. Representative figures from three independent experiments. E, desensitization rates of N- or C-terminally tagged P2X2 channels estimated in GT1 cells by single cell [Ca2+]i recordings. Data are from 18 to 26 cells. P < 0.05 versus P2X constructs. F, functional heteromultimer formation by YFP-tagged P2X2 subunits. Chimeric P2X22/X3 subunit was expressed with P2X2a-YFP or P2X2e -YFP in GT1 cells and stimulated with 10 µM {alpha}beta-methylene ATP. Notice the difference in the rate of calcium signal decay. Homomeric P2X2a and P2X2e receptors were insensitive to 10 µM {alpha}beta-methylene (traces not shown). P2X2a/X3 ex chimera represents a mutant subunit in which the extracellular regions from Ile66 to Tyr310 of rat P2X2a were replaced with Val60 to Phe3002aof rat P2X3.

 

In addition, no difference was observed in steady-state anisotropy measurements of cells expressing the GFP- or YFP-tagged receptors (data not shown). We also confirmed the expression of tagged subunit proteins on the Western blot membrane (Fig. 6C). Furthermore, differently tagged subunits were coimmunoprecipitated (Fig. 6D). The accelerated rates of receptor desensitization for the spliced isoforms were preserved after N- and C-terminal tagging (Fig. 6E). Finally, the heteromer-specific channel response was detected by coexpressing YFP-tagged P2X2a or P2X2e subunits with chimeric P2X2a/X3ex, in which the extracellular domain of P2X2a was replaced with that of P2X3 (Koshimizu et al., 2002Go). As shown in Fig. 6F, both heteromeric channels responded to 10 µM {alpha}beta-methylene ATP application with a rise in [Ca2+]i, but the faster decay of [Ca2+]i was seen in cells expressing YFP-tagged P2X2e + P2X2a/X3ex. None of native P2X2 subunits made homomeric channels responsive to 10 µM {alpha}beta-methylene ATP (Koshimizu et al., 2002Go, and data not shown for YFP-tagged P2X2a or P2X2e). Therefore, tagged P2X2 subunits retained the ability to form functional homomeric and heteromeric channels without affecting the protein expression, trafficking, and functionalities of P2X subunits.

We then titrated the expression levels of the P2X2-Luc and P2X2-YFP constructs similar to those expressing Luc and YFP alone. When P2X2a-Luc and P2X2a-YFP were coexpressed, subunit oligomerization was specifically detected by BRET, which occurred from the C-terminally tagged Luc to YFP (Fig. 7A). The signal intensity ratio at 535 nm/480 nm was significantly higher in cells expressing P2X2a-Luc and P2X2a-YFP (0.52 ± 0.02 n = 10) than those of control cells expressing Luc and P2X2a-YFP (0.38 ± 0.03, n = 4) or P2X2a-Luc and YFP (0.35 ± 0.03, n = 4). In contrast, the coexpression of the {alpha}1b-adrenergic receptor, a G-protein-coupled plasma membrane receptor with heptahelical membrane topology, together with the P2X2a subunit, did not induce significant change in BRET value (Fig. 7A). The protein expression levels (Fig. 7B) or stimulations with 100 µM ATP (Fig. 7C) did not alter BRET signals in mouse P2X2 receptors.


Figure 7
View larger version (15K):
[in this window]
[in a new window]
 
Fig. 7. Homo-oligomer formation detected by luminescence spectra measurements. A, HEK cells coexpressing Luc and YFP constructs were collected in suspension and subjected to spectra measurement (n = 4). Bioluminescence was initiated by the addition of 5 µM coelenterazine h. Signal intensities at 480 nm and 535 nm were considered to arise from Luc and a combination of Luc and YFP, respectively. Asterisks indicate a significant increase in BRET ratio compared with that of Luc and YFP expressed cells (P < 0.01). B, BRET signal was stable in cells expressing different levels of tagged channels. cDNA (3.5 or 2 µg) for YFP- and Luc-tagged P2X2e were cotransfected into HEK cells grown in 10-cm dishes and YFP fluorescence (bars, left axis) and BRET signals were measured (bullet, right axis). Results were from three independent experiments. *, P < 0.05. C, time course of BRET signals in response to 100 µM ATP application. Data presented were from single traces and similar results were observed in three independent experiments.

 
Intersubunit interactions of the cytoplasmic tails were detected by BRET analysis in any combination of full-length or spliced P2X2 subunits. Moreover, shortening the C termini by progressive splicing resulted in accelerated energy transfer efficiency, as shown in Fig. 8. Specifically, the BRET signal of homomeric P2X2e receptors was significantly stronger than that of control construct Luc-YFP, in which Luc and YFP were fused directly by a spacer consisting of two amino acids (Gly-Thy); BRET signals were 1.03 ± 0.02 and 0.94 ± 0.01 for P2X2e and the Luc-YFP construct, respectively (n = 5). Furthermore, interactions between the C and N termini of adjacent subunits were detected as the BRET signal, and C-terminal splicing significantly increased the BRET efficiency (Fig. 9). These results indicate that C-terminal splicing enhances the intersubunit interactions between the C termini and the N- and C-terminal ends of P2X2 receptors.


Figure 8
View larger version (18K):
[in this window]
[in a new window]
 
Fig. 8. C-terminal splicing enhances BRET efficiency between receptor C termini. A, either Luc or YFP was tagged at the C-terminal end of P2X2 subunit and coexpressed in HEK cells (top). Bioluminescence from a suspension of cells was evoked by the addition of 5 µM coelenterazine h, and spectra measurement was performed without excitation light. The light intensity was plotted against wavelength (three graphs). B, the wavelength for maximum luminescence intensity detected from Luc was at 480 nm and for maximum fluorescence intensity from YFP fluorescence at 535 nm. The ratios of light intensities at 535/480 nm were compared and significant differences were observed in all combinations of P2X2 variants (mean ± S.E.M. values, n = 4).

 

Figure 9
View larger version (18K):
[in this window]
[in a new window]
 
Fig. 9. C-terminal splicing enhances BRET efficiency between subunits tagged at the N and C termini. A, BRET between C-terminal Luc and N-terminal GFP was examined (top). Light intensities detected were plotted against wavelength (three graphs). B, the wavelengths for peak intensities were at 480 nm for Luc and at 515 nm for GFP. The ratios of light intensities at 515/480 nm were compared and the significant differences were observed in all combinations of P2X2 variants (mean ± S.E.M. values, n = 4).

 

The splicing pattern-dependent conformational changes were not due to the shortening of the C-terminal, because the consequence of C-terminal mutation was sequence-specific. For example, deletion of two amino acids at the splicing junction of P2X2b, where channel function had been altered in previous mutagenesis studies, resulted in an increase in BRET efficiency, whereas mutation at the C terminus had no effect (Fig. 10, A and B). When these P2X2b receptor mutants were examined functionally, the desensitization rate of P2X2b{Delta}370-371 was significantly faster than those of P2X2b and P2X2b{Delta}402-403 (Fig. 10C). These results indicate that removal of a critical C-terminal amino acid stretch could have a sequence-specific effect on both the subunit interaction and the channel activity.


Figure 10
View larger version (16K):
[in this window]
[in a new window]
 
Fig. 10. Effects of deletion of amino acids from the P2X2b C terminus results in conformational change. Two consecutive amino acids at the splicing junction, Val370 and Val371, or at the C-terminal end, Gln402 and Leu403, of P2X2b subunit were deleted and either Luc or YFP was connected to the C-terminal ends. BRET between C-terminal Luc and YFP of the mutant and original P2X2b receptors were examined in transfected HEK cells. A, spectra measurements of cell suspensions. Intensities of light emitted from Luc and YFP were plotted against wavelength. B, the ratios of light intensities at 515/480 nm were compared and the significant differences are indicated by an asterisk (P < 0.05, n = 4-6). C, desensitization rates of mutant and original P2X2b receptors were measured from single cell [Ca2+]i changes induced by 100 µM ATP. An asterisk indicates significant differences (P < 0.05). Data presented were from six transfection experiments.

 

To examine whether increased BRET at cytoplasmic tails corresponds to tight subunit assembly in P2X2e channels, P2X2a-YFP or P2X2e-YFP was coimmunoprecipitated with Flag-P2X2a-Luc using anti-Flag antibody, and the immunocomplexes were washed with increasing concentrations of detergent (Fig. 11). This treatment removed part of P2X2e-YFP bond to Flag-P2X2a-Luc, but not P2X2a-YFP (Fig. 11). Thus, the intersubunit interactions at C termini, which can be detected by BRET, do not necessarily correlate with biochemical tightness of subunit assembly.


Figure 11
View larger version (32K):
[in this window]
[in a new window]
 
Fig. 11. A decrease of FLAG-P2X2a-Luc and P2X2e-YFP heteromeric complex, but not FLAG-P2X2a-Luc and and P2X2a-YFP homomeric complex, after an increase in washing stringency of immunoprecipitated channels. A, cotransfected subunits were immunoprecipitated with anti-FLAG antibody as described under Materials and Methods and washed with increasing concentrations of Nonidet P-40. Copurified YFP-tagged P2X2a and P2X2e were detected on the Western blot membrane. B, the amount of YFP-tagged P2X2a and P2X2e subunits were normalized with FLAG-tagged P2X2a-Luc. Results from three experiments were presented. *, P < 0.05 compared with the normalized band intensity of 0.5% Nonidet P-40.

 

    Discussion
 Top
 Abstract
 Materials and Methods
 Results
 Discussion
 References
 
In this study, we analyzed the expression of P2X2 receptors in mouse pituitary cells and the functional significance of intersubunit interactions occurring at the receptor N and C termini was evaluated by measuring current and calcium signaling. Our results indicate that mouse pituitary express three forms of P2X2 receptors: the full-size P2X2a and the spliced forms P2X2b and P2X2e, the latter two forms missing 69 and 90 residues in their C termini, respectively. Compared with rat pituitary P2X2 receptors, all three mouse forms have additional 13 N-terminal residues. Analysis of exon-intron boundaries in the mouse P2X2 gene by both molecular cloning and sequence database searches indicated that the P2X2 gene is composed of eleven exons and that the last exon contains the entire cytoplasmic C-tail and half of the second transmembrane domain. To generate C-terminal splicing variants in the pituitary, it is necessary to use cryptic splicing donor/acceptor sites in the last exon. Although such tissue-specific splicing machinery acting upon the primary P2X2 transcript needs to be examined more closely, the forced expression of P2X2a in either neuronal GT1 cells or kidney HEK cell did not produce shorter subunits, enabling us to analyze the splicing pattern-specific function.

Among the P2X2 isoforms examined here and in the previous reports (Housley et al., 1995Go; Simon et al., 1997Go; Chen and Bobbin, 1998Go; Koshimizu et al., 1998bGo; Parker et al., 1998Go; Troyanovskaya and Wackym, 1998Go), P2X2e exhibited the fastest desensitization rate, as estimated by current measurements. The fast desensitization rate of mouse P2X2e receptor found in this study was apparently comparable with the rates of rapidly desensitizing P2X1 and P2X3 receptors reported previously (North, 2002Go), whereas the EC50 for ATP for this receptor was comparable with the full-sized P2X2a receptor. The rate of P2X2b receptor desensitization was faster than P2X2a but slower than P2X2e receptors and comparable with rates of P2X4 receptor desensitization. These C-terminal deletions in turn effectively reduced the peak amplitude and duration of calcium signals. Finally, P2X2e spliced form was specific for pituitary tissue. Because the ion-permeating pores of P2X receptors are formed by three subunits (Nicke et al., 1998Go; Jiang et al., 2003Go; Barrera et al., 2005Go) and three splicing variants could be derived from the same primary P2X2 transcript, it is probable that a single pituitary cell expresses a series of homo- and heteromeric P2X2 channels.

The present results suggest that the amino acid length of the P2X2 C terminus is not a primary determinant of C terminus-dependent channel desensitization, because the deletion of two amino acids at the splicing acceptor site, but not at the distal C-terminal end, resulted in accelerated rates of desensitization. Previous studies of the C terminus-dependent desensitization of rat P2X2 (Koshimizu et al., 1999Go; Smith et al., 1999Go) also showed that mutants possessing shorter C termini than that of P2X2e retained the full channel activity, and that two candidate amino acid regions were critical for C terminus-dependent desensitization: the Val383 residue and the negative static charges of the adjacent six amino acids located at the splicing donor site (Koshimizu et al., 1999Go; Smith et al., 1999Go). These residues were absent in the P2X2e C terminus, possibly explaining the accelerated desensitization rate associated with P2X2e. These results may indicate that P2X2b and P2X2e serve as a dominant negative tool to limit duration of signaling and cellular responsiveness by homo- and heteromeric P2X2 receptors, such as P2X2/P2X3 receptors in sensory pathways and other purinergic systems (Ralevic and Burnstock, 1998Go).

The structure of the N-terminal tail also influences the duration of P2X2-mediated channel signaling in the continuous presence of an agonist. Species-specific differences were found when comparing the desensitization rates of human and rat P2X2b subunits; unlike rat P2X2b, human P2X2b desensitized at a rate similar to that of human P2X2a (Lynch et al., 1999Go). The main structural distinction between human and rat P2X2b subunits is at the N termini, in which the human ortholog has an additional 13 amino acids. However, our data suggested that this difference in sequence does not explain the observed species-specific difference in activity, because deletion of the first 13 amino acids at the N terminus of mouse P2X2 resulted in accelerated desensitization rates of all C-terminal splicing isoforms. Instead, we found that the combined effect of shortening both the cytoplasmic N- and C-terminal ends on overall channel function of mouse P2X2 was additive, accelerating the desensitization rates.

We also explored the presence and functional significance of intersubunit interactions at the N and C termini of pituitary P2X2 receptor subunits in living cells. Our results indicate that P2X2 receptors connected to GFP/YFP or Luc were fully functional, and the N- and C-terminal interactions were possible among all P2X2 subunit combinations. Patch-clamp analysis from open channel lifetimes, open channel noise, and kinetics indicate that the P2X2a receptors are not independent but have positive cooperativity (Ding and Sachs, 2002Go). Thus, it might be possible that subunit interactions could occur, in part, between cytoplasmic tails of clustered P2X2 channels. The efficiency of energy transfer changes in accordance with the distance and the relative orientation of energy donor and acceptor pair. Steady-state fluorescence anisotropy measurements revealed that there were no significant differences among the P2X2 constructs investigated here, suggesting that C-terminal splicing resulted in reductions of relative C-terminal distance and increased intersubunit interaction. In line with our previous study reporting that heteromers composed of full-length and spliced C termini of rat P2X2 desensitized faster than P2X2a homomers but more slowly than P2X2b homomers (Koshimizu et al., 2002Go), we also show here that heteromultimer formation with P2X2e-YFP and P2X2a/X3ex resulted in an acceleration in desensitization rate, compared with that of channels formed by P2X2a-YFP and P2X2a/X3ex. These results indicate that there is a consistent parallelism between the level of constitutive intersubunit interactions and the rates of receptor desensitization. Furthermore, intersubunit interactions at the spliced C termini increased BRET signals in both homomeric and heteromeric channels.

A recent study revealed that differences at the distal C-terminal tail structure of rat and mouse P2X2a expressed in X. laevis oocytes account for a transition in pore permeability, from sodium-selective to organic cation-permeable, which is seen in rat P2X2a but not in mouse homologs (Eickhorst et al., 2002Go). In addition, FRET signals detected by total reflection microscopy decrease during the prolonged activation of rat P2X2a receptors expressed in HEK cells with a time course similar to pore dilation. The wild-type and mutant channels that did not undergo permeability changes also showed no evidence of cytosolic gating motions (Fisher et al., 2004Go). In full agreement with these results, we found that BRET signals were not altered after stimulation of mouse P2X2a with ATP and that C-terminal splicing variants had constitutive intersubunit interactions. These results suggest that the strength of mutual interactions at the P2X2 C terminus positively correlates with BRET/FRET efficiency and negatively correlates with the signal length by P2X2 receptors during continuous or repetitive agonist applications. The relationship between intersubunit interaction and function of the other ligand-gated channel was also reported recently; in the AMPA type glutamate receptor, an increase in the likelihood of subunit interaction at the ligand-binding domain results in decreased receptor desensitization (Sun et al., 2002Go). Thus, analyzing intersubunit interactions in relation to receptor activity could further advance our understanding of conformational constraint and transitions of the ligand-gated channel molecule.

In conclusion, our results demonstrated the critical contribution of spliced C-tails in the formation of functional channel through subunit interaction. Shortening the subunit C terminus and deleting the N termini had an additive effect on the desensitization rates of P2X2 receptors. The distinct desensitization patterns caused by C-terminal splicing were preserved even after N-terminal deletions. Moreover, diverse heteromeric P2X2 channels are formed in any combination of the three P2X2 splicing subunits found in the pituitary. The rates of receptor desensitization of these homo- and heteromeric channels positively correlated to the energy transfer efficiency between tagged subunits. These results suggest that the extent of P2X2 subunit interactions at cytoplasmic tails in the absence of ATP could play a key role in shaping the ATP-dependent opening of channels and calcium signaling in pituitary and other cell types.


    Footnotes
 
This study was supported by grants-in-aid from the Ministry of Education, Science, Sports, Culture and Technology of Japan (to T.K. and G.T.), the 21st Century COE program "Knowledge Information Infrastructure for Genome Science", by the Special Coordination Fund for Promoting Science and Technology (to G.T.), and by the Intramural Research Program of the National Institute of Child Health and Human Development, National Institutes of Health (to K.K., M-L.H., and S.S.S.).

The nucleotide sequences for mouse P2X2a, P2X2b, and P2X2e been deposited in the GenBank database under GenBank have accession numbers AY044240 [GenBank] , AB094664 [GenBank] , and AB094663 [GenBank] , respectively.

ABBREVIATIONS: BRET, bioluminescent resonance energy transfer; Luc, luciferase; P2X, ATP-gated receptor-channels; GFP, green fluorescent protein; RT-PCR, reverse transcriptase-polymerase chain reaction; RACE, rapid amplification of cDNA ends; HEK, human embryonic kidney; GT1 cells, gonadotropin-releasing hormone-secreting GT1-7 immortalized neurons; YFP, yellow fluorescent protein.

Address correspondence to: Dr. Gozoh Tsujimoto, Department of Genomic Drug Discovery Science, Graduate School of Pharmaceutical Sciences, Kyoto University Faculty of Pharmaceutical Sciences, Kyoto University, Yoshida Shimoadachi-cho, Sakyo-ku, Kyoto 606-8501, Japan. E-mail: gtsuji{at}pharm.kyoto-u.ac.jp


    References
 Top
 Abstract
 Materials and Methods
 Results
 Discussion
 References
 
Barrera NP, Ormond SJ, Henderson RM, Murrell-Lagnado RD, and Edwardson JM (2005) Atomic force microscopy imaging demonstrates that P2X2 receptors are trimers but that P2X6 receptor subunits do not oligomerize. J Biol Chem 280: 10759-10765.[Abstract/Free Full Text]

Beckstead MJ, Weiner JL, Eger EI 2nd, Gong DH, and Mihic SJ (2000) Glycine and gamma-aminobutyric acidA receptor function is enhanced by inhaled drugs of abuse. Mol Pharmacol 57: 1199-1205.[Abstract/Free Full Text]

Boue-Grabot E, Archambault V, and Seguela P (2000) A protein kinase C site highly conserved in P2X subunits controls the desensitization kinetics of P2X2 ATP-gated channels. J Biol Chem 275: 10190-10195.[Abstract/Free Full Text]

Boue-Grabot E, Barajas-Lopez C, Chakfe Y, Blais D, Belanger D, Emerit MB, and Seguela P (2003) Intracellular cross talk and physical interaction between two classes of neurotransmitter-gated channels. J Neurosci 23: 1246-1253.[Abstract/Free Full Text]

Boue-Grabot E, Emerit MB, Toulme E, Seguela P, and Garret M (2004) Cross-talk and co-trafficking between rho1/GABA receptors and ATP-gated channels. J Biol Chem 279: 6967-6975.[Abstract/Free Full Text]

Brake AJ, Wagenbach MJ, and Julius D (1994) New structural motif for ligand-gated ion channels defined by an ionotropic ATP receptor. Nature (Lond) 371: 519-523.[CrossRef][Medline]

Brandle U, Spielmanns P, Osteroth R, Sim J, Surprenant A, Buell G, Ruppersberg JP, Plinkert PK, Zenner HP, and Glowatzki E (1997) Desensitization of the P2X2 receptor controlled by alternative splicing. FEBS Lett 404: 294-298.[CrossRef][Medline]

Chen C and Bobbin RP (1998) P2X receptors in cochlear Deiters' cells. Br J Pharmacol 124: 337-344.[CrossRef][Medline]

Denlinger LC, Fisette PL, Sommer JA, Watters JJ, Prabhu U, Dubyak GR, Proctor RA, and Bertics PJ (2001) Cutting edge: the nucleotide receptor P2X7 contains multiple protein- and lipid-interaction motifs including a potential binding site for bacterial lipopolysaccharide. J Immunol 167: 1871-1876.[Abstract/Free Full Text]

Ding S and Sachs F (2002) Evidence for non-independent gating of P2X2 receptors expressed in Xenopus oocytes. BMC Neurosci 3: 17.[Medline]

Eickhorst AN, Berson A, Cockayne D, Lester HA, and Khakh BS (2002) Control of P2X(2) channel permeability by the cytosolic domain. J Gen Physiol 120: 119-131.[Medline]

Fisher JA, Girdler G, and Khakh BS (2004) Time-resolved measurement of state-specific P2X2 ion channel cytosolic gating motions. J Neurosci 24: 10475-10487.[Abstract/Free Full Text]

Gendreau S, Schirmer J, and Schmalzing G (2003) Identification of a tubulin binding motif on the P2X2 receptor. J Chromatogr B 786: 311-318.

He ML, Zemkova H, Koshimizu T, Tomic M, and Stojilkovic SS (2003) Intracellular calcium measurements as a method in studies on activity of purinergic P2X receptor channels. Am J Physiol 285: C467-C479.

Housley GD, Greenwood D, Bennett T, and Ryan AF (1995) Identification of a short form of the P2xR1-purinoceptor subunit produced by alternative splicing in the pituitary and cochlea. Biochem Biophys Res Commun 212: 501-508.[CrossRef][Medline]

Housley GD, Kanjhan R, Raybould NP, Greenwood D, Salih SG, Jarlebark L, Burton LD, Setz VC, Cannell MB, Soeller C, et al. (1999) Expression of the P2X2 receptor subunit of the ATP-gated ion channel in the cochlea: implications for sound transduction and auditory neurotransmission. J Neurosci 19: 8377-8388.[Abstract/Free Full Text]

Jiang LH, Kim M, Spelta V, Bo X, Surprenant A, and North RA (2003) Subunit arrangement in P2X receptors. J Neurosci 23: 8903-8910.[Abstract/Free Full Text]

Khakh BS, Bao XR, Labarca C, and Lester HA (1999) Neuronal P2X transmittergated cation channels change their ion selectivity in seconds. Nat Neurosci 2: 322-330.[CrossRef][Medline]

Khakh BS, Fisher JA, Nashmi R, Bowser DN, and Lester HA (2005) An angstrom scale interaction between plasma membrane ATP-gated P2X2 and alpha4beta2 nicotinic channels measured with fluorescence resonance energy transfer and total internal reflection fluorescence microscopy. J Neurosci 25: 6911-6920.[Abstract/Free Full Text]

Kim M, Jiang LH, Wilson HL, North RA, and Surprenant A (2001) Proteomic and functional evidence for a P2X7 receptor signalling complex. EMBO (Eur Mol Biol Organ) J 20: 6347-6358.[CrossRef][Medline]

Koshimizu T, Koshimizu M, and Stojilkovic SS (1999) Contributions of the C-terminal domain to the control of P2X receptor desensitization. J Biol Chem 274: 37651-37657.[Abstract/Free Full Text]

Koshimizu T, Tomic M, Koshimizu M, and Stojilkovic SS (1998a) Identification of amino acid residues contributing to desensitization of the P2X2 receptor channel. J Biol Chem 273: 12853-12857.[Abstract/Free Full Text]

Koshimizu T, Tomic M, Van Goor F, and Stojilkovic SS (1998b) Functional role of alternative splicing in pituitary P2X2 receptor-channel activation and desensitization. Mol Endocrinol 12: 901-913.[Abstract/Free Full Text]

Koshimizu T, Ueno S, Tanoue A, Yanagihara N, Stojilkovic SS, and Tsujimoto G (2002) Heteromultimerization modulates P2X receptor functions through participating extracellular and C-terminal subdomains. J Biol Chem 277: 46891-46899.[Abstract/Free Full Text]

Kozak M (1989) The scanning model for translation: an update. J Cell Biol 108: 229-241.[Abstract/Free Full Text]

Lynch KJ, Touma E, Niforatos W, Kage KL, Burgard EC, van Biesen T, Kowaluk EA, and Jarvis MF (1999) Molecular and functional characterization of human P2X2 receptors. Mol Pharmacol 56: 1171-1181.[Abstract/Free Full Text]

Nagai T, Ibata K, Park ES, Kubota M, Mikoshiba K, and Miyawaki A (2002) A variant of yellow fluorescent protein with fast and efficient maturation for cell-biological applications. Nat Biotechnol 20: 87-90.[CrossRef][Medline]

Newbolt A, Stoop R, Virginio C, Surprenant A, North RA, Buell G, and Rassendren F (1998) Membrane topology of an ATP-gated ion channel (P2X receptor). J Biol Chem 273: 15177-15182.[Abstract/Free Full Text]

Nicke A, Baumert HG, Rettinger J, Eichele A, Lambrecht G, Mutschler E, and Schmalzing G (1998) P2X1 and P2X3 receptors form stable trimers: a novel structural motif of ligand-gated ion channels. EMBO (Eur Mol Biol Organ) J 17: 3016-3028.[CrossRef][Medline]

North RA (2002) Molecular physiology of P2X receptors. Physiol Rev 82: 1013-1067.[Abstract/Free Full Text]

Parker MS, Larroque ML, Campbell JM, Bobbin RP, and Deininger PL (1998) Novel variant of the P2X2 ATP receptor from the guinea pig organ of Corti. Hear Res 121: 62-70.[CrossRef][Medline]

Ralevic V and Burnstock G (1998) Receptors for purines and pyrimidines. Pharmacol Rev 50: 413-492.[Abstract/Free Full Text]

Royle SJ, Bobanovic LK, and Murrell-Lagnado RD (2002) Identification of a non-canonical tyrosine-based endocytic motif in an ionotropic receptor. J Biol Chem 277: 35378-35385.[Abstract/Free Full Text]

Simon J, Kidd EJ, Smith FM, Chessell IP, Murrell-Lagnado R, Humphrey PP, and Barnard EA (1997) Localization and functional expression of splice variants of the P2X2 receptor. Mol Pharmacol 52: 237-248.[Abstract/Free Full Text]

Smith FM, Humphrey PP, and Murrell-Lagnado RD (1999) Identification of amino acids within the P2X2 receptor C-terminus that regulate desensitization. J Physiol 520: 91-99.[Abstract/Free Full Text]

Sun Y, Olson R, Horning M, Armstrong N, Mayer M, and Gouaux E (2002) Mecha nism of glutamate receptor desensitization. Nature (Lond) 417: 245-253.[CrossRef][Medline]

Torres GE, Egan TM, and Voigt MM (1998) Topological analysis of the ATP-gated ionotropic P2X2 receptor subunit. FEBS Lett 425: 19-23.[CrossRef][Medline]

Troyanovskaya M and Wackym PA (1998) Evidence for three additional P2X2 purinoceptor isoforms produced by alternative splicing in the adult rat vestibular end-organs. Hear Res 126: 201-209.[CrossRef][Medline]

Vial C, Roberts JA, and Evans RJ (2004) Molecular properties of ATP-gated P2X receptor ion channels. Trends Pharmacol Sci 25: 487-493.[CrossRef][Medline]

Virginio C, MacKenzie A, Rassendren FA, North RA, and Surprenant A (1999) Pore dilation of neuronal P2X receptor channels. Nat Neurosci 2: 315-321.[CrossRef][Medline]




This article has been cited by other articles:


Home page
J. Neurosci.Home page
R. K. Tittle and R. I. Hume
Opposite Effects of Zinc on Human and Rat P2X2 Receptors
J. Neurosci., October 29, 2008; 28(44): 11131 - 11140.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
L. L. Shang, A. E. Pfahnl, S. Sanyal, Z. Jiao, J. Allen, K. Banach, J. Fahrenbach, D. Weiss, W. R. Taylor, A. M. Zafari, et al.
Human Heart Failure Is Associated With Abnormal C-Terminal Splicing Variants in the Cardiac Sodium Channel
Circ. Res., November 26, 2007; 101(11): 1146 - 1154.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
M. D'Arco, R. Giniatullin, M. Simonetti, A. Fabbro, A. Nair, A. Nistri, and E. Fabbretti
Neutralization of Nerve Growth Factor Induces Plasticity of ATP-Sensitive P2X3 Receptors of Nociceptive Trigeminal Ganglion Neurons
J. Neurosci., August 1, 2007; 27(31): 8190 - 8201.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.105.019802v1
69/5/1588    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Koshimizu, T.-a.
Right arrow Articles by Tsujimoto, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Koshimizu, T.-a.
Right arrow Articles by Tsujimoto, G.


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics